Vaccine Administration
Laura Mackenzie
Learning Objectives
- Correctly identify relevant shoulder, buttock, and thigh anatomy.
- Be able to locate relevant shoulder, buttock, and thigh anatomy through palpation.
- Understand and perform various anatomical landmarking techniques for use in vaccination.
- Choose appropriate needle lengths for individual patient presentations.
- Choose an appropriate site for administration.
- Understand the consequences of vaccination errors.
Clinical case study:
Kyle, a 35yo male, has attended your pharmacy to receive his yearly influenza vaccination. Kyle frequents the gym regularly and has above average muscle size around his shoulders. He has attended wearing a long-sleeved shirt. Determine the appropriate needle length for Kyle, and decide how you will position and administer the vaccine.
Patient specific choices:
Needle length guidelines
Needle length guidelines vary depending on method of delivery, age of patient, and size of patient. 1–6 Guidelines as per the Australian Immunisation Handbook1 are found in Table 1.
Table 1: Needle length guidelines.
|
Injection method |
Age/size of individual |
Gauge |
Needle length |
Angle to plane of skin |
|---|---|---|---|---|
|
Intramuscular |
Pre-term infant (<37 weeks gestation) up to 2 months of age |
23-25 |
16mm |
90° |
|
Intramuscular |
Very small infant (<12 months) |
23-25 |
16mm |
90° |
|
Intramuscular |
Infant (<12 months) |
22-25 |
25mm |
90° |
|
Intramuscular |
Paediatric (>12 months) |
22-25 |
25mm |
90° |
|
Intramuscular |
Adult |
22-25 |
25mm |
90° |
|
Intramuscular |
Very large or obese adult |
22-25 |
38mm |
90° |
|
Subcutaneous |
All |
25-27 |
16mm |
45° |
|
Intradermal |
All |
26-27 |
10mm |
5-15° |
Source: Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook, Australian Government Department of Health, Disability and Ageing, Canberra, 2025. Immunisation.Handbook@Health.gov.au Used with permission.
Considerations:
On occasion multiple vaccinations are required in the same visit. When two are scheduled together it is recommended to administer one in each limb (i.e. both thighs for an infant, or both deltoids for a child).1, 3, 7 If more than two are scheduled for a single visit they must be administered 2.5cm apart. 1, 3, 7 For a larger deltoid and thigh, two can be administered to the same limb. For smaller deltoids where a 2.5cm distance cannot be achieved it is recommended to administer to an additional limb (e.g. both deltoids and one thigh for a child patient). 1, 3, 7
For individuals with limb differences (e.g. congenital limb malformation, amputations etc.) the hierarchy of preferential sites is: deltoid (on the unaffected side if possible), anterolateral thigh, ventrogluteal.1
For children or adults where the limbs are casted or braced, the unaffected limb is preferred where possible. 8 For children under 12 months in a bilateral leg brace such as a SPICA splint or cast for congenital hip dysplasia would prevent access to the anterolateral thigh, so vaccination should be timed to occur during change over periods for the brace/cast. 8 Of note, increased aftercare time should be utilised, to monitor for swelling that may be impacted by the brace and compromise circulation. 8 If swelling occurs, the child’s paediatrician or physiotherapist should be contacted as soon as possible.1, 8
For individuals with lymphoedema, or those undergoing treatment for cancers that may increase risk of developing lymphoedema (such as breast cancer) care should be taken when selecting an administration site. 9-11 While there is limited evidence to support the claim, localised swelling reactions post vaccination could theoretically worsen lymphoedema symptoms. 1 Where possible, the other limb or an alternative site should be considered. 1
Positioning the limb:
Always ensure appropriate exposure when performing vaccination. Skin exposure is paramount for both vaccination and visualisation of the anatomical landmarks. 1, 12 Clothing that cannot be sufficiently moved (e.g. rolled up or down) to allow for adequate exposure, should be removed. 1, 12
Positioning the administrator:
Where possible, the administrator should be positioned at a similar height to the patients, i.e. if the patient is seated the administrator should also be seated.13-14 This ensures that angle of approach is in line with the target site for administration and is not coming from above to below (for example where the patient is seated, and the administrator is standing) or vice versa.
Anatomical landmarking techniques:
Anatomical landmarking techniques are designed to locate the thickest section of the muscle, while avoiding sensitive structures at risk of injury during administration.12, 14 Locating the thickest section of the muscle assists in optimal vaccine delivery and resultant immune response.13-14 Numerous anatomical landmarking techniques described in the literature are deemed appropriate for use during the administration process by governing bodies, however, it should be noted that very few have evidence to support their accuracy and are largely theoretical in their appropriateness.
Preparing the patient:
Distraction techniques
Utilising distraction techniques can be useful for infants, children, or individuals with needle phobias. 15–17 Reducing the distress an individual may feel during vaccination assists in reducing fear of future vaccinations, and reducing a child’s distress may help parents or guardians comfortably present them on time for future vaccinations.15, 16
Various tools and methods exist for reducing distress. (Box 1.)16-22
Box 1: Distraction techniques.
- BUZZY® bee (or similar vibrational tools)
- Nursing/breastfeeding
- Swaddling an infant (loosely)
- 15-25% Sucrose drops or other sweet liquids immediately prior
- Toys shaken in front of a child
- Virtual reality headsets
- NeedleCalm device
- Playing or singing to music
- Bubble or windmill toy blowing
Preparing the skin
Antiseptic wipes such as alcohol swabs or other disinfecting agents are only necessary if the skin is visibly unclean.1, 23 If used, the skin must be allowed to dry completely prior to administration, as it reduces the risk of skin irritation and prevents the inactivation of live attenuated vaccines.1, 23
Anaesthetics, vapocoolant sprays, and analgesics
Analgesics such as paracetamol are not routinely recommended for pre- or post vaccination, except in the case of administration of the Meningococcal B vaccine for patients under 2 years of age for the reduction of fever. 1, 2
Topical anaesthetics such as lignocaine/prilocaine e.g. EMLA cream should not be routinely utilised and should only be considered in the case of severe needle phobia or excessive dislike of needles. If used, they should be applied 30-60 minutes prior to administering the vaccination. 1, 17 Topical anaesthetics can be used in patients over the age of 12 months but is contraindicated in individuals under 12 months due to the risk of methaemoglobinaemia.19
For adults, vapocoolant sprays can be used 10-15 seconds prior to administration in order to cool and numb the area. This method is not recommended for children, as the cooling sensation can draw attention to the administration process, and some children may perceive the cold sensation as pain. 1
Vaccination under sedation is considered a last resort method to be used when all other methods have been exhausted.1 Jurisdictional specific Specialist Immunisation Services should be contacted for advice should this be necessary, as local health services and facilities may have different operating policies and regulations for sedated services.1
Deltoid vaccination site:
Choosing an appropriate site for administration:
The deltoid muscle group is the recommended site of administration for individuals over the age of 12 months.1
Anatomy:


Palpitation technique:
Position the patient comfortably, with the skin exposed. Assess the area visually, observing for bony prominences, bruising, or other deformities or abnormalities. Using the pads of the second and third fingers press gently but firmly on the midpoint of the clavicle. Press the pads of the fingers along the line of the clavicle, moving distally towards the acromioclavicular joint. Continue moving laterally from the acromioclavicular joint to the acromion process (shoulder tip). This can also be located by finding the spine of the scapula and palpating distally along the ridge to the shoulder tip. Deltoid tuberosity can be difficult to palpate depending on the size of the individual. It is most easily located by following the V line of the anterior and posterior deltoid fibres, to their inferior point at the midshaft of the humorous. The deltoid tuberosity is the small bumpy protuberance at this point.
Positioning the limb:
For adult and larger paediatric patients, the arm should be positioned comfortably either resting on an arm rest or with the hand placed on the patients’ hip when in seated. These positions relax the deltoid muscle group, with the slight abduction of the arm positioning the axillary nerve more superiorly and posteriorly.24 If the patient is supine the arm should be resting in slight abduction with the hand placed on the patients’ hip or stomach.
For infants and smaller paediatric patients, it is often preferable to have the patient sitting on a parent or guardians lap with their arms resting on the arms of the adult. Infants can be nursed (breastfed) during vaccination as a distraction technique, in which case the child is cradled in the adults arms (while the adult is seated).
Paediatric patients can be seated on the adults’ lap either in the cuddle position with the child’s legs placed between the adults’ legs while facing sideways (Image 3), or in the straddle position (Image 4) with their legs at the outside of the adults’ legs and facing inwards.


Anatomical landmarking techniques:
2-3 fingerbreadths below the acromion process 13
This is the most commonly taught and utilised method for anatomical landmarking, likely due to its simplicity and speed of application. The vaccinator palpates for the acromion process and places their fingers inferiorly to this point (Image 5). Number of fingers used is determined by the sex of the vaccinator, not the sex or size of the patient, with male vaccinators using two fingers and female vaccinators using three fingers. This method uses the vaccinators fingers (which remain in contact with the patient during the administration process) to cover the subacromial space and the subacromial/subdeltoid bursae. The needle is then inserted inferiorly to this point, into the deltoid muscle. Limitations of this technique includes variability in location due to vaccinator size (and thereby finger size and distance from the acromion process), and the possibility of the vaccination being delivered either anteriorly or posteriorly depending on angle of approach.

Inverted triangle14
The inverted triangle technique is a continuation of the fingerbreadth technique, where once the 2-3 finger gap has been established the vaccinator uses their other hand (or visualises) to form a V shape using the thumb and index finger with both touching the fingers of the other hand (Image 6). The centre point of this inverted triangle is the appropriate space for IM deltoid vaccination. This method reduces the variability in anterior or posterior location for administration, which is considered to be protective of both the sub-acromial space, and the axillary nerve. It is limited however by the visualisation skills of the practitioner, or their ability to use both hands during landmarking.

Midpoint between the acromion process and the deltoid tuberosity1
In this technique the vaccinator palpates for the acromion process with one hand, and the deltoid tuberosity with the other. The middle point between these two landmarks is the location for administration (Image 7). This method is less commonly used, likely due to the use of both hands during landmarking, and the difficulty in palpating the deltoid tuberosity in some patients.

4cm inferior to and in line with the posterior aspect of the acromion process25
Using this method, the vaccinator palpates the acromion process and locates the posterior aspect. From this point, a 4cm line is visualised inferiorly to locate the thickest section of the deltoid (Image 8). This point is typically more posterior than the other methods described above.
This technique is supported by a study using Computerised Tomography (CT imaging) to locate the thickest section of the deltoid.25 While the most accurate, it is limited by its precision and accuracy of palpation required. Of note, this study was only performed in adult patients and without further study should not be generalised to a paediatric or older adult population group which more commonly has smaller limbs.

Anterolateral thigh (vastus lateralis) vaccination site:
Choosing an appropriate site for administration:
For use in children under the age of 12 months, or for individuals of sufficient frailty to warrant not using the deltoid muscle, or those with other considerations limiting the use of the deltoid site.2,3,7 It is recommended for these individuals due to its large size and lack of neurovascular structures. If used in individuals over 12 months, only use the site for vaccines that are less locally reactive such as MMR.1
Anatomy:

Palpation technique:
Position the patient comfortably, with the skin exposed. Assess the area visually, observing for bony prominences, bruising, or other deformities or abnormalities. Using first the heel/palm of your hand, then the pads of the second and third fingers, identify the anterior superior iliac spine by locating the iliac crest, and palpating anteriorly (and slightly inferiorly) towards the bony protuberance that dips distally. Visualise the pubic tubercle, which will sit inferiorly to the inguinal grooves and will be in line with the greater trochanter. The midpoint between the anterior superior iliac spine and the pubic tubercle is marker one and should rest at the level of the greater trochanter. Using the other hand, palpate for the base of the patella which will be the superior aspect of the bony surface at the front of the knee, the midpoint of which is marker two. Drawing a line between the two points will mark the optimal site of vaccine administration, at the vastus lateralis muscle. 1
Positioning the limb:
Infant patients can be positioned prone or seated on their parent or guardians lap, or cradled in their arms in prone or supine, with the hip and knee in a flexed position.

Paediatric patients can be seated on the adults lap either supine, in the cuddle position with the child’s legs placed between the adults legs while facing sideways (Image 11), or in the straddle position with their legs at the outside of the adults legs and facing inwards (Image 12).


An adult patient can be positioned supine with their legs resting comfortably (Image 13). Placing a pillow under the patients’ knees can help reduce lower back discomfort and allow for greater muscle relaxation due to the hip and knee flexion. If performed in seated, the patient should be resting with their feet comfortably touching the floor. (Image 14).


Ventrogluteal (Gluteus medius) vaccination site:
Choosing an appropriate site for administration:
For use in children under the age of 12 months, or for individuals of sufficient frailty to warrant not using the deltoid muscle, or those with other considerations limiting the use of the deltoid site.1 It can also be useful when multiple vaccinations are delivered in one session.18 The ventrogluteal site injects into the Gluteus Medius muscle, largely free of neurovascular structures.
A ventrogluteal site should not be confused with a dorsogluteal site (buttocks), which uses the Gluteus Maximus muscle and is in close proximity to the sciatic nerve.1
Anatomy:

Palpation technique:
Position the patient comfortably, with the skin exposed. Assess the area visually, observing for bony prominences, bruising, or other deformities or abnormalities.
Using the heel of the hand and palm, press gently but firmly at the side of the hip inferior to the gluteal fold to locate the greater trochanter. Identify the anterior superior iliac spine by locating the iliac crest and palpating anteriorly (and slightly inferiorly) towards the bony protuberance that dips distally. Palpate for the greater trochanter and place the palm of the non-dominant hand over this point with the thumb pointing towards the patient’s groin/umbilicus. Point the index finger towards the anterior superior iliac spine, while the middle finger stretches to point towards the iliac crest. This will form a V shape between the middle and index fingers. The midpoint of this V is the Gluteus Medius and should rest approximately 5-8cm inferior to the iliac crest.1
Positioning the limb:
Adult or larger paediatric patients should be placed in standing with the hands/elbows resting on a plinth (Image 16), or prone with a pillow under the hips (Image 17), or in side lying with the hips and knees slightly flexed (Image 18).



Infant or smaller paediatric patients should be positioned in prone, with their legs in unsupported hanging off the side of a plinth or bed or supported in a parent or guardians lap (Image 19). The child’s arms should be tucked underneath their chest. Placing the hip and knee into slight internal rotation will assist in relaxing the gluteal muscles.

Shoulder Injury Related to Vaccine Administration (SIRVA):
Aetiology and incidence
Shoulder Injury Related to Vaccine Administration (SIRVA) is an iatrogenic group of pathologies proposed to occur because of incorrect vaccine administration technique or location.6 Incidence of SIRVA is considered rare (3.7 per 100,000 doses)26 and proportionally forms 1.5-2.5% of reports to pharmacovigilance agencies.26, 27 SIRVA is largely reported as being unrelated to vaccine types or included adjuvants, however there is growing evidence that chemical make-up of vaccines may impact risk of SIRVA.26 In order to prevent SIRVA, regardless of vaccine type, care should be taken when administering vaccinations and appropriate anatomical landmarking techniques should be applied every time a vaccine is administered.13, 14, 28
SIRVA is thought to occur due to either direct damage to a structure from the needle penetration, or indirectly from a localised response from the vaccine adjuvants and antigens.12, 29, 30 Direct needle point injuries are associated with immediate pain and deficits, while indirect injuries are associated with a slower development of symptoms, resulting from a progressive inflammatory response and fibrotic changes in the tissues, and a lytic effect of vaccine antigen and adjuvants which may contribute to indirect SIRVA.12 Due to the large amount of potential resultant pathologies, and a paucity of evidence, true pathophysiology for SIRVA has not been fully determined.
Females are disproportionately affected by SIRVA forming 70-85% of reports,26, 27, 31-33 though causes for this are debated. Despite many vaccinations occurring during childhood, children are seldom affected by SIRVA, with adults aged 18-64 forming 85% of reports and children aged 0 months to 17 years forming less than 1%.26
Resultant pathologies
Resultant pathologies are highly dependent on the underlying structure of the shoulder that has been affected during the administration process. Broad categories of structures that have been documented as affected in SIRVA include skeletal, muscle/tendon, capsule, nerve, and bursae. Reported pathologies include adhesive capsulitis, bursitis, rotator cuff pathology, nerve palsy, neuritis, arthritis, impingement, osteonecrosis, abscess, etc.26, 27, 31, 32, 34
Management
Initial management for any suspected SIRVA should include controlling of any localised reactions through use of paracetamol or ibuprofen if fever is greater than 38.5° or if there is pain at the injection site.1
Early referral to first contact musculoskeletal practitioners (e.g. General practitioners or Physiotherapists) is important for timely assessment and management of SIRVA induced pathologies.12 Specific patient management is highly dependent on resultant pathologies.
Patient outcomes
Majority of SIRVA research utilises retrospective data collection, usually from large databases such as Eudravigilance (European Medicines Agency)35, VAERS (Vaccine Adverse Event Reporting Scheme, United States of America)36, or TGA (Therapeutic Goods Administration, Australia)37. Knowledge of patient outcomes is therefore limited to the initial data collected by these agencies, which often lists patient outcomes as duration of symptoms in days or in stratified blocks such as resolving/resolved/not-resolved.
To the best current knowledge, patient outcomes are highly variable dependent on the resultant pathology and can last from several weeks to several years with the potential for permanent deficits. Injuries in which soft tissue structures such as the bursae or tendons are affected typically resolve in weeks to months.26 In contrast, injuries to the nervous system structures, joint capsule, or skeletal system taking months to years to resolve. Injuries to the skeletal system and nervous system are more at risk of having permanent deficits.26
Other vaccine administration errors:
If needle length guidelines are not followed appropriately and short needles are used to deliver a vaccine intramuscularly, it may risk being delivered subcutaneously due to under-penetration. 1 If given subcutaneously it may not be considered as an immunogenic route, and thus an invalid dose. Consideration should be given to repeating the dose should this occur. 1 Intramuscular vaccines given subcutaneously, particularly aluminium-adjuvanted vaccines, are at a greater risk of causing local adverse events. 1, 6 Rabies and other lyssavirus vaccines, particularly the Rabipur Inactivated Rabies Virus Vaccine (PCECV) must be repeated if delivered subcutaneously.1
Infants receiving the oral rotavirus vaccine may spit or vomit during or after administration. If most of the dose is expelled within minutes of administration, a single repeat dose can be given immediately or during the same visit.1 Should only a small part of the dose be expelled, a repeat dose is not required as the incomplete dose remains valid.1
If a vaccination is delivered resulting in less than half of an appropriate dose being administered, this is considered invalid and should be repeated. 1 This may occur if a vaccine delivered either intramuscularly or subcutaneously cannot be completed (for example if the needle becomes disconnected from the syringe), or should an antigen be delivered using a dosage for an incorrect age formulation. 1
If an individual receives higher than the approved dose, for example where the dose is drawn from a multidose vial, the dose does not need to be repeated.37
Should anatomical landmarking not be appropriately completed and a vaccine is delivered into an improper location, it may be considered a valid dose if still delivered using the appropriate method (e.g intramuscularly). Local or systemic adverse events are more likely to occur and should be monitored for.1, 12

What to do if an administration error occurs:
Disclose to the individual and/or their caregiver what has occurred.
Discuss potential local or systemic reactions to monitor for, and when to seek further care from a medical professional.
Submit an adverse event report to the Therapeutic Goods Administration (TGA)37, or to local state/territory health departments.
If a delivered dose is considered invalid but has already been submitted to the Australian Immunisation Registrar (AIR)38, contact them directly for advice.
Clinical case study continued:
Kyle, a 35yo male, has attended your pharmacy to receive his yearly influenza vaccination. Kyle frequents the gym regularly and has above average muscle size around his shoulders. He has attended wearing a long-sleeved shirt. You decide to use a 22-25 gauge, 38mm length needle to administer the vaccination into Kyles left deltoid. You position him in seated and ask him to remove his arm completely from his shirt so that you can perform anatomical landmarking using the finger breadth technique and have full visualisation of the deltoid.
Quiz
References
- Australian Technical Advisory Group on Immunisation. Australian Immunisation Handbook. Australian Government, Department of Health. Australia. 2018. https://immunisationhandbook.health.gov.au
- Diggle L, Deeks J. Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial. BMJ 2000;321:931-3 doi: 10.1136/bmj.38906.704549.7C
- Diggle L, Deeks JJ, Pollard AJ. Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial. BMJ 2006;333:571.
- Kroger AT, Duchin J, Vázquez M. General best practice guidelines for immunization. Best practices guidance of the Advisory Committee on Immunization Practices (ACIP). Atlanta, GA: Centers for Disease Control and Prevention; 2017. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html- external site
- Poland GA, Borrud A, Jacobson RM, et al. Determination of deltoid fat pad thickness: implications for needle length in adult immunization. JAMA 1997;277:1709-11. doi:10.1001/jama.1997.03540450065037
- Cook IF. Best vaccination practice and medically attended injection site events following deltoid intramuscular injection. Hum Vaccin Immunother. 2015;11(5):1184-91. doi: 10.1080/21645515.2015.1017694
- Cook IF, Williamson M, Pond D. Definition of needle length required for intramuscular deltoid injection in elderly adults: an ultrasonographic study. Vaccine. 2006;24(7):937-40. doi: 10.1016/j.vaccine.2005.08.098
- Clarke S, McKay, M. An audit of spica cast guidelines for parents and professionals caring for children with developmental dysplasia of the hip. Journal of Orthopedic Nursing. 2006;10:128-37. doi: 10.1016/j.joon.2006.04.002
- National Breast and Ovarian Cancer Centre (NBOCC). Review of research evidence on secondary lymphoedema: incidence, prevention, risk factors and treatment. Surry Hills: NBOCC; 2008. Available from: https://web.archive.org/web/20240424061834/https://www.canceraustralia.gov.au/sites/default/files/publications/slerw-review-research-secondary-lymphoedema_504af03e2a20c.pdf
- Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001;93(2):96-111. doi: 10.1093/jnci/93.2.96
- Petrek JA, Pressman PI, Smith RA. Lymphedema: current issues in research and management. CA Cancer J Clin. 2000;50(5):292-307; quiz 8-11. doi: 10.1002/caac.6170500505
- Mackenzie L, Bousie J, Newman P, Bushell M. Shoulder Injuries Related to Vaccine Administration. Australian Pharmacist. 2022;40(11):60-8.
- Australian Immunisation Handbook. Avoiding shoulder injury related to vaccine administration. Australian Government, Department of Health. Australia. 2021. https://immunisationhandbook.health.gov.au/resources/publications/avoiding-shoulder-injury-related-to-vaccine-administration
- Bancsi A, Houle SKD, Grindrod KA. Getting it in the right spot: Shoulder injury related to vaccine administration (SIRVA) and other injection site events. Can Pharm J (Ott). 2018;151(5):295-9. doi: 10.1177/1715163518790771
- Ellerton K, Tharmarajah H, Medres R, Brown L, Ringelblum D, Vogel K, et al. The VRIMM study: Virtual Reality for IMMunisation pain in young children-protocol for a randomised controlled trial. BMJ Open. 2020;10(8):e038354. doi: 10.1136/bmjopen-2020-038354
- Schechter NL, Zempsky WT, Cohen LL, McGrath PJ, McMurtry CM, Bright NS. Pain reduction during pediatric immunizations: evidence-based review and recommendations. Pediatrics. 2007;119(5):e1184-98. doi: 10.1542/peds.2006-1107
- Felt BT, Mollen E, Diaz S, Renaud E, Zeglis M, Wheatcroft G, et al. Behavioral interventions reduce infant distress at immunization. Arch Pediatr Adolesc Med. 2000;154(7):719-24. doi: 10.1001/archpedi.154.7.719
- Reis EC, Roth EK, Syphan JL, Tarbell SE, Holubkov R. Effective pain reduction for multiple immunization injections in young infants. Arch Pediatr Adolesc Med. 2003;157(11):1115-20. doi: 10.1001/archpedi.157.11.1115
- Halperin SA, McGrath P, Smith B, Houston T. Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response. J Pediatr. 2000;136(6):789-94. doi: 10.1016/S0022-3476(00)64169-0
- Kassab M, Sheehy A, King M, Fowler C, Foureur M. A double-blind randomised controlled trial of 25% oral glucose for pain relief in 2-month old infants undergoing immunisation. Int J Nurs Stud. 2012;49(3):249-56. doi: 10.1016/j.ijnurstu.2011.09.013
- Lie D. Minimizing needle pain: a new device may help. 2010.
- Baxter AL, Cohen LL, McElvery HL, Lawson ML, von Baeyer CL. An integration of vibration and cold relieves venipuncture pain in a pediatric emergency department. Pediatr Emerg Care. 2011;27(12):1151-6. doi: 10.1097/PEC.0b013e318237ace4
- National Health and Medical Research Council (NHMRC). Australian guidelines for the prevention and control of infection in healthcare. Canberra: NHMRC; 2019. https://www.nhmrc.gov.au/about-us/publications/australian-guidelines-prevention-and-control-infection-healthcare-2019
- Cheung S, Fitzpatrick M, Lee TQ. Effects of shoulder position on axillary nerve positions during the split lateral deltoid approach. J Shoulder Elbow Surg. 2009;18(5):748-55. doi: 10.1016/j.jse.2008.12.001
- Mardourian M, Hao KA, Wiggins W, Arias J, King JJ, Wright TW, et al. Optimizing needle length and site choice for adult immunization. Vaccine. 2023;41(33):4836-43. doi: 10.1016/j.vaccine.2023.06.031
- Mackenzie LJ, Bousie JA, Newman P, Cunningham J, Woodward AP, Silk-Jones J, et al. What three years of COVID-19 vaccine administration reveals about the incidence of shoulder injury related to vaccine administration (SIRVA). Vaccine. 2025;51:126892. doi: 10.1016/j.vaccine.2025.126892
- Hibbs BF, Ng CS, Museru O, Moro PL, Marquez P, Woo EJ, et al. Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017. Vaccine. 2020;38(5):1137-43. doi: 10.1016/j.vaccine.2019.11.023
- Bancsi A, Houle SKD, Grindrod KA. Shoulder injury related to vaccine administration and other injection site events. Can Fam Physician. 2019;65(1):40-2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6347325
- Sunderland S. The anatomy and physiology of nerve injury. Muscle Nerve. 1990;13(9):771-84. doi: 10.1002/mus.880130903
- Cooke TD, Jasin HE. The Pathogenesis of Chronic Inflammation in Experimental Antigen-Induced Arthritis- 1. The Role of Antigen on the Local Immune Response. Arthritis Rheum. 1972a;15(4):327-37. doi: 10.1002/art.1780150402
- Mackenzie LJ, Bushell M-JA, Newman P, Bousie JA. Shoulder injury related to vaccine administration (SIRVA): What do we know about its incidence and impact? Exploratory Research in Clinical and Social Pharmacy. 2022;8:100183. doi: 10.1016/j.rcsop.2022.100183
- Hesse EM, Atanasoff S, Hibbs BF, Adegoke OJ, Ng C, Marquez P, et al. Shoulder Injury Related to Vaccine Administration (SIRVA): Petitioner claims to the National Vaccine Injury Compensation Program, 2010-2016. Vaccine. 2020;38(5):1076-83. doi: 10.1016/j.vaccine.2019.11.032
- Housel LA, McClenathan BM, Huh J, Klaric J. Post-Immunization Arthropathy: The DoD Experience. Womack Army Medical Centre, Fort Bragg, NC. 2020. p. 1.
- Wright JO, Wiggins W, Smith MS, King JJ, Wright TW. Shoulder Pain and Dysfunction After Vaccination: A Systematic Review. JBJS Rev. 2023;11(1): e22.00134. doi:10.2106/JBJS.RVW.22.00134
- European Medicines Agency. European database of suspected adverse drug reaction reports [Internet]. 2021. Available from: https://www.adrreports.eu/en/eudravigilance.html
- Vaccine Adverse Event Reporting System (VAERS) 1990 – 07/02/2021. CDC WONDER On-line Database [Internet]. United States of America, Department of Health and Human Services: Public Health Service (PHS). 2021. Available from: https://wonder.cdc.gov/vaers.html.
- TGA. Theraputic Goods Administration. Database of Adverse Event Notifications. [Internet] 2021 Available from: https://www.tga.gov.au
- Australia S. Australian Immunisation Register Canberra: Australian Government; 2025. Available from: https://www.servicesaustralia.gov.au/australian-immunisation-register.
Media Attributions
- Skeletal anatomy © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Vaccination specific anatomy © Lyn Todd is licensed under a CC BY (Attribution) license
- Anterolateral thigh in seated cuddle position (Infant or small paediatric) © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Straddle position © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Fingerbreadth technique © Lyn Todd is licensed under a CC BY (Attribution) license
- Inverted triangle technique © Lyn Todd is licensed under a CC BY (Attribution) license
- Midpoint technique © Laura Mackenzie is licensed under a CC BY (Attribution) license
- 4cm inferior to and inline with the posterior aspect of the acromion process © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Anterolateral thigh in supine (Infant) © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Anterolateral thigh in supine (Adult) © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Anterolateral thigh in seated (Adult) © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Ventrogluteal skeletal anatomy in prone. © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Ventrogluteal in standing (Adult) © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Ventrogluteal in prone (Adult) © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Ventrogluteal in side lying (Adult) © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Ventrogluteal in prone (Infant) © Laura Mackenzie is licensed under a CC BY (Attribution) license
- Figure 1: Considerations for administration errors. © Laura Mackenzie is licensed under a CC BY (Attribution) license